Interestingly, we found that knockdown of DLEU1 significantly inhibited DLEU1 expression, increased miR‐133a expression, and inhibited IGF‐1R expression and its downstream PI3K/AKT pathway in xenograft tumours. The gene discussed is AKT1; the disease is neoplasm.